CCEA clears Glenmark, Aurobindo proposals worth Rs 4,187 cr

Last Updated: Tuesday, April 7, 2015, 21:49

Pharmaceutical majors Glenmark and Aurobindo's foreign investment proposals, worth Rs 4,187 crore, were approved by the government Tuesday.

RBI notifies new FDI policy for medical devices segment

Last Updated: Monday, February 2, 2015, 20:23

The Reserve Bank on Monday notified the changes in the FDI policy allowing 100 percent foreign direct investment in medical devices segment.

Panel for blanket ban on FDI in brown field pharma units

Last Updated: Monday, December 22, 2014, 20:38

Government must put a blanket ban on FDI in brown field pharma units, a Parliamentary panel Monday said asserting that under existing policy domestic firms faced 'decimation' due to takeover by MNCs and it could affect India's ability to produce low-cost quality generic drugs.

FDI in pharma jumps to $1.25 bn during Apr-Nov period

Last Updated: Sunday, February 2, 2014, 12:19

FDI in drugs and pharmaceuticals was USD 581 million during April-November 2012, according to the latest data of the Department of Industrial Policy and Promotion (DIPP).

Govt retains 100% FDI in existing pharma units

Last Updated: Wednesday, January 8, 2014, 16:18

Government Wednesday decided to retain the policy of allowing 100 percent foreign investment in the existing pharma firms, brushing aside concerns about non- availability of affordable drugs in view of MNCs takeovers.

FDI in pharma sector jumps 86.5% during April-Oct period

Last Updated: Sunday, January 5, 2014, 11:13

FDI in the pharmaceutical sector jumped by 86.5 percent to USD 1.08 billion during April- October period of the current fiscal amid concerns over continuous mergers and acquisitions of domestic drug makers by multinationals.

No clear gainers if Pharma FDI is capped

Last Updated: Saturday, November 30, 2013, 11:55

Moreover, Indian pharma industry is pretty fragmented, so it is difficult for few players to control the whole pharma market.

Cabinet defers decision on FDI in pharma and housing

Last Updated: Thursday, November 28, 2013, 22:17

The Cabinet Thursday deferred decision on relaxing FDI norms for the housing sector and reducing foreign investment limit to 49 percent in rare and critical areas of the pharma segment.

Govt may review FDI policy in pharma, housing tomorrow

Last Updated: Wednesday, November 27, 2013, 18:54

The Cabinet is likely to take a decision Thursday on relaxing FDI norms for the housing sector and reducing foreign investment limit to 49 percent in rare and critical areas of the pharma segment.

Cabinet defers consideration of pharma, housing FDI proposals

Last Updated: Monday, November 25, 2013, 19:42

The strategy for the WTO ministerial conference in Bali next month was also not discussed.

Cabinet likely to decide on FDI in pharma, housing today

Last Updated: Monday, November 25, 2013, 09:22

With serious concerns being raised from various departments regarding the acquisition of Indian drug firms by global multinational entities, the government is likely to consider reducing the foreign direct investment cap in the pharma sector.